Evidence map›Paper›PMID 42327756›Full record

SynthesisFrontiers in immunology2026

Diagnosis and treatment strategies for airway involvement in relapsing polychondritis: a comprehensive review.

Pengcheng Zhou, Wei Yu, Jianli Ma, Wensheng Zhang, Yan Dong, Chengshi He

Abstract readSystematic Review
In one paragraph

Synthesis in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Pengcheng Zhou *Department of Respiratory Medicine, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan, China.
Wei Yu *Department of Respiratory Medicine, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan, China.
Jianli Ma *Clinical Medical School, Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan, China.
Wensheng ZhangDepartment of Respiratory Medicine, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan, China.
Yan DongDepartment of Respiratory Medicine, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan, China.
Chengshi HeDepartment of Respiratory Medicine, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Relapsing polychondritis (RP) is a rare and complex autoimmune disease primarily affecting cartilage tissue. In particular, RP leads to inflammatory damage of airway cartilage, resulting in severe complications such as airway narrowing and tracheomalacia, which has a significant effect on patients' quality of life and prognosis. Although the clinical manifestations of RP are diverse, airway involvement has become a focal point of research and clinical attention because of its high incidence and potential lethality. Currently, the early recognition and accurate diagnosis of airway lesions remain challenging, with imaging and bronchoscopic examinations playing a key role in the assessment of structural and functional abnormalities of the airway. Although mainstream treatment consists of traditional immunosuppressants and glucocorticoids, their efficacy is limited and side effects are significant. In recent years, interventional surgery and comprehensive airway management strategies have gradually become important adjunctive treatment methods. This paper provides a systematic review of the clinical characteristics, diagnostic techniques, and diversified treatment approaches for airway involvement in RP and evaluates the latest research progress, aiming to enhance clinical physicians' understanding and treatment levels of airway lesions in this disease and to promote the development of individualized treatment plans, thereby improving patients' clinical prognosis and quality of life.

Indexed as

Polychondritis, RelapsingBronchoscopyHumansImmunosuppressive AgentsPrognosisQuality of LifeTracheomalaciaImmunosuppressive Agentsairway involvementairway managementbronchoscopydiagnosisrelapsing polychondritistracheomalaciatreatment

Identifiers

PMID42327756
PMCPMC13275720

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.